1. Home
  2. VIVS vs NCRA Comparison

VIVS vs NCRA Comparison

Compare VIVS & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$2.16

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$0.38

Market Cap

5.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIVS
NCRA
Founded
2007
2002
Country
United States
Taiwan
Employees
13
22
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
VIVS
NCRA
Price
$2.16
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
78.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.38
N/A
Revenue Next Year
$15.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$0.35
52 Week High
$5.30
$2.40

Technical Indicators

Market Signals
Indicator
VIVS
NCRA
Relative Strength Index (RSI) 53.08 27.46
Support Level $2.08 N/A
Resistance Level $2.45 $0.58
Average True Range (ATR) 0.18 0.06
MACD 0.01 0.01
Stochastic Oscillator 74.51 6.77

Price Performance

Historical Comparison
VIVS
NCRA

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: